Aprogen Pharmaceuticals Inc (003060) — Cash Flow Quality Index
Aprogen Pharmaceuticals Inc (003060) has a Cash Flow Quality Index of -13.36x as of March 2023. Operating cash flow of ₩-14.74 Billion is below net income of ₩1.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 003060 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aprogen Pharmaceuticals Inc Cash Flow Quality Index (2015–2022)
Historical Cash Flow Quality Index for Aprogen Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 003060 cash flow conversion.
Annual Cash Flow Quality Index for Aprogen Pharmaceuticals Inc (2015–2022)
Year-by-year earnings quality comparison for Aprogen Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.28x | ₩25.73 Billion | ₩7.84 Billion | ▲ +527.2% |
| 2021 | -0.77x | ₩-6.23 Billion | ₩8.10 Billion | ▼ -206.9% |
| 2020 | 0.72x | ₩8.09 Billion | ₩11.25 Billion | ▲ +7.4% |
| 2015 | 0.67x | ₩1.85 Billion | ₩2.76 Billion | — |